Chemocentryx reported $19.7M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amgen AMGN:US $ 1.38B 130M
AstraZeneca AZN:LN 2.57B 76M
Bayer BAYN:GR 3.75B 226M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Chemocentryx CCXI:US $ 19.7M 3.44M
GlaxoSmithKline GSK:LN 2.5B 183M
Glaxosmithkline GSK:US 2.5B 183M
Johnson & Johnson JNJ:US $ 6.07B 641M
Macrogenics MGNX:US $ 15.23M 198K
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Novartis NOVN:VX 3.71B 190M
Omeros OMER:US $ 21.56M 3.51M
Pfizer PFE:US $ 2.79B 134M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Takeda 4502:JP 219.84B 14.55B
Teva Pharmaceutical TEVA:IT 832M 16M
YTE INCY:US $ 168.86M 15.06M